21 results on '"Poyanmehr, Reza"'
Search Results
2. Minimally Invasive Approach for Replacement of the Ascending Aorta towards the Proximal Aortic Arch.
- Author
-
Helms, Florian, Deniz, Ezin, Krüger, Heike, Zubarevich, Alina, Schmitto, Jan Dieter, Poyanmehr, Reza, Hinteregger, Martin, Martens, Andreas, Weymann, Alexander, Ruhparwar, Arjang, Schmack, Bastian, and Popov, Aron-Frederik
- Subjects
THORACIC aorta ,AORTA ,MINIMALLY invasive procedures ,TOTAL ankle replacement ,LENGTH of stay in hospitals ,OVERALL survival - Abstract
Objectives: In recent years, minimally invasive approaches have been used with increasing frequency, even for more complex aortic procedures. However, evidence on the practicability and safety of expanding minimally invasive techniques from isolated operations of the ascending aorta towards more complex operations such as the hemiarch replacement is still scarce to date. Methods: A total of 86 patients undergoing elective surgical replacement of the ascending aorta with (n = 40) or without (n = 46) concomitant proximal aortic arch replacement between 2009 and 2023 were analyzed in a retrospective single-center analysis. Groups were compared regarding operation times, intra- and postoperative complications and long-term survival. Results: Operation times and ventilation times were significantly longer in the hemiarch replacement group. Despite this, no statistically significant differences between the two groups were observed for the duration of the ICU and hospital stay and postoperative complication rates. At ten-year follow-up, overall survival was 82.6% after isolated ascending aorta replacement and 86.3% after hemiarch replacement (p = 0.441). Conclusions: Expanding the indication for minimally invasive aortic surgery towards the proximal aortic arch resulted in comparable postoperative complication rates, length of hospital stay and overall long-term survival compared to the well-established minimally invasive isolated supracommissural ascending aorta replacement. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
3. Long-term outcomes after intraoperative extracorporeal membrane oxygenation during lung transplantation
- Author
-
Ius, Fabio, Aburahma, Khalil, Boethig, Dietmar, Salman, Jawad, Sommer, Wiebke, Draeger, Helge, Poyanmehr, Reza, Avsar, Murat, Siemeni, Thierry, Bobylev, Dmitry, Optenhoefel, Joerg, Wiesner, Olaf, Greer, Mark, Schwerk, Nicolaus, Hoeper, Marius M., Welte, Tobias, Haverich, Axel, Kuehn, Christian, Warnecke, Gregor, Gottlieb, Jens, and Tudorache, Igor
- Published
- 2020
- Full Text
- View/download PDF
4. Prediction of transplant outcome after 24-hour ex vivo lung perfusion using the Organ Care System in a porcine lung transplantation model
- Author
-
Sommer, Wiebke, Salman, Jawad, Avsar, Murat, Hoeffler, Klaus, Jansson, Katharina, Siemeni, Thierry N., Knoefel, Ann-Kathrin, Ahrens, Linda, Poyanmehr, Reza, Tudorache, Igor, Braubach, Peter, Jonigk, Danny, Haverich, Axel, and Warnecke, Gregor
- Published
- 2019
- Full Text
- View/download PDF
5. Risk factors, prevention, and therapy of intraluminal stent thrombosis in frozen elephant trunk prostheses--what we know so far.
- Author
-
Helms, Florian, Schmack, Bastian, Weymann, Alexander, Poyanmehr, Reza, Martens, Andreas, Salman, Jawad, Zubarevich, Alina, Schmitto, Jan D., Ruhparwar, Arjang, and Popov, Aron-Frederik
- Published
- 2024
- Full Text
- View/download PDF
6. Impact of Intercostal Artery Reinsertion on Neurological Outcome after Thoracoabdominal Aortic Replacement: A 25-Year Single-Center Experience.
- Author
-
Helms, Florian, Poyanmehr, Reza, Krüger, Heike, Schmack, Bastian, Weymann, Alexander, Popov, Aron-Frederik, Ruhparwar, Arjang, Martens, Andreas, and Natanov, Ruslan
- Subjects
- *
AORTA , *ARTERIES , *SPINAL cord , *ARTIFICIAL respiration , *SURVIVAL rate , *PARAPLEGIA - Abstract
Background: Intercostal artery reinsertion (ICAR) during thoracoabdominal aortic replacement remains controversial. While some groups recommend the reinsertion of as many arteries as possible, others consider the sacrifice of multiple intercostals practicable. This study investigates the impact of intercostal artery reinsertion or sacrifice on neurological outcomes and long-term survival after thoracoabdominal aortic repair. Methods: A total of 349 consecutive patients undergoing thoracoabdominal aortic replacement at our institution between 1996 and 2021 were analyzed in a retrospective single-center study. ICAR was performed in 213 patients, while all intercostal arteries were ligated and sacrificed in the remaining cases. The neurological outcome was analyzed regarding temporary and permanent paraplegia or paraparesis. Results: No statistically significant differences were observed between the ICAR and non ICAR groups regarding the cumulative endpoint of transient and permanent spinal cord-related complications (12.2% vs. 11.8%, p = 0.9). Operation, bypass, and cross-clamp times were significantly longer in the ICAR group. Likewise, prolonged mechanical ventilation was more often necessary in the ICAR group (26.4% vs. 16.9%, p = 0.03). Overall long-term survival was similar in both groups in the Kaplan–Meier analysis. Conclusion: Omitting ICAR during thoracoabdominal aortic replacement may reduce operation and cross-clamp times and thus minimize the duration of intraoperative spinal cord hypoperfusion. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Mice with cardiac-restricted overexpression of Myozap are sensitized to biomechanical stress and develop a protein-aggregate-associated cardiomyopathy
- Author
-
Frank, Derk, Rangrez, Ashraf Y., Poyanmehr, Reza, Seeger, Thalia S., Kuhn, Christian, Eden, Matthias, Stiebeling, Katharina, Bernt, Alexander, Grund, Christine, Franke, Werner W., and Frey, Norbert
- Published
- 2014
- Full Text
- View/download PDF
8. Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantation
- Author
-
Ius, Fabio, Verboom, Murielle, Sommer, Wiebke, Poyanmehr, Reza, Knoefel, Ann-Kathrin, Salman, Jawad, Kuehn, Christian, Avsar, Murat, Siemeni, Thierry, Erdfelder, Caroline, Hallensleben, Michael, Boethig, Dietmar, Schwerk, Nicolaus, Mueller, Carsten, Welte, Tobias, Falk, Christine, Haverich, Axel, Tudorache, Igor, and Warnecke, Gregor
- Published
- 2018
- Full Text
- View/download PDF
9. Intraoperative Extracorporeal Circulatory Support in Lung Transplantation for Pulmonary Fibrosis.
- Author
-
Salman, Jawad, Bernhard, Beeke-Alina, Ius, Fabio, Poyanmehr, Reza, Sommer, Wiebke, Aburahma, Khalil, Alhadidi, Hani, Siemeni, Thierry, Kuehn, Christian, Avsar, Murat, Haverich, Axel, Warnecke, Gregor, and Tudorache, Igor
- Abstract
Venous-arterial extracorporeal membrane oxygenation (ECMO) is an established technique for intraoperative cardiopulmonary support in patients undergoing lung transplantation. Patients with pulmonary fibrosis have a higher risk to require it. The aim of this study was to identify risk factors for the need of intraoperative ECMO use. Records of patients undergoing lung transplantation for pulmonary fibrosis at our institution between January 2010 and May 2018 were retrospectively reviewed. Univariate logistic regression analysis was used for statistical identification of risk factors. There were 105 patients (34%) who required intraoperative ECMO support (ECMO+ group), and 203 (66%) did not (ECMO− group). Preoperative proof of pulmonary hypertension was identified as a risk factor for intraoperative ECMO support (odds ratio [OR], 3.8; 95% confidence interval [CI], 2.2-6.5; P <.01). Revealed mean pulmonary arterial pressure values exceeding 50 mm Hg and pulmonary vascular resistance values exceeding 9.4 Wood units were identified as risk factors for the need of intraoperative ECMO use with a prediction probability of 70%. Increased recipient body surface area (OR, 0.2; 95% CI, 0.1-0.5; P <.01) emerged as a protective factor against intraoperative ECMO (Hosmer-Lemeshow statistic, P =.71) as well as higher cardiac output (OR, 0.7; 95% CI, 0.6-0.9; P <.01). The postoperative course was more complicated in the ECMO+ group, whereas survival at 5 years did not differ among groups (70% vs 69%, P =.79). Pulmonary hypertension with elevated pulmonary vascular resistance values predicts the need of intraoperative ECMO in patients receiving lung transplantation for pulmonary fibrosis. Although the postoperative course was more complicated in the ECMO+ group, long-term survival did not differ significantly. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
10. Increased frequency of CD4+CD25highCD127low T cells early after lung transplant is associated with improved graft survival – a retrospective study.
- Author
-
Ius, Fabio, Salman, Jawad, Knoefel, Ann‐Kathrin, Sommer, Wiebke, Nakagiri, Tomoyuki, Verboom, Murielle, Siemeni, Thierry, Poyanmehr, Reza, Bobylev, Dmitry, Kuehn, Christian, Avsar, Murat, Erdfelder, Caroline, Hallensleben, Michael, Boethig, Dietmar, Hecker, Hartmut, Schwerk, Nicolaus, Mueller, Carsten, Welte, Tobias, Falk, Christine, and Preissler, Gerhard
- Subjects
T cells ,SUPPRESSOR cells ,LUNG transplantation ,RETROSPECTIVE studies ,BLOOD cells - Abstract
Summary: In this retrospective study, we analyzed the presence of any association of three CD4+CD25high regulatory T‐cell subpopulations at 3 weeks after lung transplantation with the later incidence of chronic lung allograft dysfunction and graft survival. Among lung‐transplanted patients between January 2009 and April 2018, only patients with sufficient T‐cell measurements at 3 weeks after transplantation were included into the study. Putative regulatory T cells were defined as CD4+CD25high T cells, detected in peripheral blood and further analyzed for CD127low, FoxP3+, and CD152+ using fluorescence‐activated cell sorting (FACS) analysis. Associations of regulatory T cells with chronic lung allograft dysfunction (CLAD) and graft survival were evaluated using Cox analysis. During the study period, 724 (71%) patients were included into the study. Freedom from chronic lung allograft dysfunction (CLAD) and graft survival amounted to 66% and 68% at 5 years. At the multivariable analysis, increasing frequencies of CD127low were associated with better freedom from CLAD (hazard ratio for each 1% increase of %CD127low, HR = 0.989, 95% CI = 0.981–0.996, P = 0.003) and better graft survival (HR = 0.991, 95% CI = 0.984–0.999, P = 0.026). A higher frequency of CD127low regulatory T cells in peripheral blood early after lung transplantation estimated a protective effect against chronic lung allograft dysfunction, mortality, and re‐transplantation. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
11. Six‐year experience with treatment of early donor‐specific anti‐HLA antibodies in pediatric lung transplantation using a human immunoglobulin‐based protocol.
- Author
-
Ius, Fabio, Müller, Carsten, Sommer, Wiebke, Verboom, Murielle, Hallensleben, Michael, Salman, Jawad, Siemeni, Thierry, Kühn, Christian, Avsar, Murat, Bobylev, Dmitry, Poyanmehr, Reza, Erdfelder, Caroline, Böthig, Dietmar, Carlens, Julia, Bayir, Lale, Hansen, Gesine, Blasczyk, Rainer, Falk, Christine, Tecklenburg, Andreas, and Haverich, Axel
- Published
- 2020
- Full Text
- View/download PDF
12. Extracorporeal membrane oxygenation as a bridge to lung transplantation may not impact overall mortality risk after transplantation: results from a 7-year single-centre experience.
- Author
-
Ius, Fabio, Natanov, Ruslan, Salman, Jawad, Kuehn, Christian, Sommer, Wiebke, Avsar, Murat, Siemeni, Thierry, Bobylev, Dmitry, Poyanmehr, Reza, and Boethig, Dietmar
- Subjects
EXTRACORPOREAL membrane oxygenation ,LUNG transplantation ,HOSPITAL mortality ,PREOPERATIVE care ,TRANSPLANTATION of organs, tissues, etc. ,SURVIVAL analysis (Biometry) ,HEALTH outcome assessment ,PATIENTS - Abstract
OBJECTIVES Extracorporeal membrane oxygenation (ECMO) has an important role in bridging patients to lung transplantation. In this study, we present our experience with pretransplant ECMO during the last 7 years and investigate its impact on graft outcomes. METHODS Records of all lung-transplanted patients at our institution between January 2010 and April 2017 were retrospectively reviewed. Graft survival was compared between patients who required pretransplant ECMO (pre-Tx ECMO+) and patients who did not (pre-Tx ECMO−). Risk factors for in-hospital mortality and graft survival were identified using a binary logistic regression and the Cox regression analyses, respectively. RESULTS Among the 917 patients transplanted during the study period, 68 (7%) required ECMO as a bridge to transplantation [awake strategy, n = 57 (84%) patients]. Median bridging time was 9 days. Among pre-Tx ECMO+ patients, the need for haemodialysis at any point during bridging emerged as an independent risk factor for in-hospital mortality (odds ratio 7.79, 95% confidence interval 1.21–50.24; P = 0.031). Although in-hospital mortality was significantly higher in pre-Tx ECMO+ versus pre-Tx ECMO− patients (15% vs 5%, P = 0.003), overall graft survival did not differ between groups (79% vs 90% and 61% vs 68% at 1 and 5 years, respectively, P = 0.13). Pretransplant ECMO did not emerge as a risk factor for graft survival in the multivariable analysis. CONCLUSIONS If applied in selected patients in a high-volume centre, pretransplant ECMO as a bridge to transplantation results in impaired, but still high in-hospital, survival and does not impact graft survival. [ABSTRACT FROM AUTHOR]
- Published
- 2018
- Full Text
- View/download PDF
13. Left Ventricular Assist Device Implantation With Outflow Graft Tunneling Through the Transverse Sinus.
- Author
-
Hanke, Jasmin S., Rojas, Sebastian V., Poyanmehr, Reza, Deniz, Ezin, Avsar, Murat, Berliner, Dominik, Shrestha, Malakh, Cebotari, Serghei, Haverich, Axel, and Schmitto, Jan D.
- Subjects
HEART assist devices ,HEART failure treatment ,PARANASAL sinuses ,VENTRICULAR outflow obstruction ,HEART transplantation complications ,PREVENTION ,THERAPEUTICS - Abstract
The article discusses the growing trends in the role and use of ventricular assist devices (VADs) in the treatment of chronic heart failure (CHF), focusing on the implantation of left ventricular assist device with outflow graft tunneling through the transverse sinus. It suggests that outflow graft tunneling through the transverse sinus is a new and innovative strategy in the prevention of outflow graft damage in cardiac transplantation or resternotomy.
- Published
- 2016
- Full Text
- View/download PDF
14. Urgent Driveline Repair Under Catecholamine Support After Total Driveline Cut.
- Author
-
Poyanmehr, Reza, Feldmann, Christina, Hanke, Jasmin, and Schmitto, Jan
- Subjects
- *
HEART assist devices , *MEDICAL equipment , *THORACOTOMY , *VASCULAR surgery ,AORTIC valve surgery - Abstract
The article discusses the case study of a 47-year-old female patient underwent LVAD implantation. Topics discussed include clinical importance of left ventricular assist devices, complications associated with transcutaneous drivelines, and her median upper hemisternotomy and anterolateral thoracotomy.
- Published
- 2017
- Full Text
- View/download PDF
15. Abstract 181.
- Author
-
Rangrez, Ashraf Y, Frank, Derk, Poyanmehr, Reza, Bernt, Alexander, and Frey, Norbert
- Published
- 2014
16. Myozap Deficiency Promotes Adverse Cardiac Remodeling via Differential Regulation of Mitogen-activated Protein Kinase/Serum-response Factor and β-Catenin/GSK-3β Protein Signaling.
- Author
-
Rangrez, Ashraf Yusuf, Eden, Matthias, Poyanmehr, Reza, Kuhn, Christian, Stiebeling, Katharina, Dierck, Franziska, Bernt, Alexander, Lüllmann-Rauch, Renate, Weiler, Hartmut, Kirchof, Paulus, Frank, Derk, and Frey, Norbert
- Subjects
- *
CARDIOMYOPATHIES , *HEART diseases , *MITOGEN-activated protein kinases , *NATRIURETIC peptides , *PHENOTYPES , *VENTRICULAR remodeling , *CARDIAC hypertrophy - Abstract
The intercalated disc (ID) is a "hot spot" for heart disease, as several ID proteins have been found mutated in cardiomyopathy. Myozap is a recent addition to the list of ID proteins and has been implicated in serum-response factor signaling. To elucidate the cardiac consequences of targeted deletion of myozap in vivo, we generated myozap-null mutant (Mzp-/-) mice. Although Mzp-/- mice did not exhibit a baseline phenotype, increased biomechanical stress due to pressure overload led to accelerated cardiac hypertrophy, accompaniedby"super"-induction of fetal genes, including natriuretic peptides A and B (Nppa/Nppb). Moreover, Mzp-/- mice manifested a severe reduction of contractile function, signs of heart failure, and increased mortality. Expression of other ID proteins like N-cadherin, desmoplakin, connexin-43, and ZO-1 was significantly perturbed upon pressure overload, underscored by disorganization of the IDs in Mzp-/- mice. Exploration of the molecular causes of enhanced cardiac hypertrophy revealed significant activation of β-catenin/GSK-3β signaling, whereas MAPK and MKL1/serum-response factor pathways were inhibited. In summary, myozap is required for proper adaptation to increased biomechanical stress. In broader terms, our data imply an essential function of the ID in cardiac remodeling beyond a mere structural role and emphasize the need for a better understanding of this molecular structure in the context of heart disease. [ABSTRACT FROM AUTHOR]
- Published
- 2016
- Full Text
- View/download PDF
17. Dysbindin is a potent inducer of RhoA-SRF-mediated cardiomyocyte hypertrophy.
- Author
-
Rangrez, Ashraf Yusuf, Bernt, Alexander, Poyanmehr, Reza, Harazin, Violetta, Boomgaarden, Inka, Kuhn, Christian, Rohrbeck, Astrid, Frank, Derk, and Frey, Norbert
- Subjects
- *
DYSBINDIN , *CARRIER proteins , *SCHIZOPHRENIA , *CARDIAC hypertrophy , *CARDIOMYOPATHIES , *SERUM response factor - Abstract
Dysbindin is an established schizophrenia susceptibility gene thoroughly studied in the context of the brain. We have previously shown through a yeast two-hybrid screen that it is also a cardiac binding partner of the intercalated disc protein Myozap. Because Dysbindin is highly expressed in the heart, we aimed here at deciphering its cardiac function. Using a serum response factor (SRF) response element reporter-driven luciferase assay, we identified a robust activation of SRI: signaling by Dysbindin overexpression that was associated with significant up-regulation of SRI: gene targets, such as Actal and Actcl. Concurrently, we identified RhoA as a novel binding partner of Dysbindin. Further phenotypic and mechanistic characterization revealed that Dysbindin induced cardiac hypertrophy via RhoA-SRF and MEK1-ERK1 signaling pathways. In conclusion, we show a novel cardiac role of Dysbindin in the activation of RhoA-SRF and MEK1-ERK1 signaling pathways and in the induction of cardiac hypertrophy. Future in viva studies should examine the significance of Dysbindin in cardiomyopathy. [ABSTRACT FROM AUTHOR]
- Published
- 2013
- Full Text
- View/download PDF
18. Delayed non-myeloablative irradiation to induce long-term allograft acceptance in a large animal lung transplantation model.
- Author
-
Hacker, Karolin S., Jansson, Katharina, Pichler, Jeanette, Salman, Jawad, Avsar, Murat, Siemeni, Thierry, Knöfel, Ann-Kathrin, Höffler, Klaus, Gottlieb, Jens, Frühauf, Jörg, Werner, Martin, Poyanmehr, Reza, Jonigk, Danny, Balzer, Michael S., Hewicker-Trautwein, Marion, Haverich, Axel, Sommer, Wiebke, and Warnecke, Gregor
- Subjects
- *
LUNG transplantation , *IRRADIATION , *CHIMERISM , *GRAFT versus host reaction , *THYMUS - Abstract
We previously induced long-term allograft acceptance in an allogeneic lung transplantation (LTx) model in miniature swine using perioperative non-myeloablative irradiation (IRR) combined with infusion of donor specific alloantigen. In order to improve clinical applicability, we delayed induction with irradiation in this study. Left sided single LTx was performed in minipigs. Group 1 received non-myeloablative irradiation (7Gy thymus and 1.5Gy whole body IRR) before LTx and a perioperative donor specific splenocyte infusion (SpTx). Group 2 received perioperative SpTx but delayed IRR three days after LTx. Group 3 was exposed to delayed IRR without SpTx. Whereas 4 out of 7 animals from the non-delayed group never rejected their grafts and were electively sacrificed on postoperative day (POD) +500, all animals from group 2 rejected their grafts before POD 108. In group 3, 3 out of 8 animals developed long-term allograft acceptance. In all groups, donor leukocyte chimerism peaked up to 20% in peripheral blood one hour after reperfusion of the lung. Group 1 maintained prolonged chimerism beyond POD 7, whereas chimerism levels in groups 2 and 3 decreased continuously thereafter. Delayed irradiation has the potential to improve long-term graft survival, yet not as efficient as a perioperative conditioning protocol. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
19. Acute Aortic Dissection Type A in Younger Patients (< 60 Years Old) - Does Full Arch Replacement Provide Benefits Compared to Limited Approach?
- Author
-
Natanov R, Shrestha ML, Martens A, Beckmann E, Krueger H, Arar M, Rudolph L, Ruemke S, Poyanmehr R, Korte W, Schilling T, Haverich A, and Kaufeld T
- Subjects
- Humans, Middle Aged, Postoperative Complications etiology, Time Factors, Retrospective Studies, Treatment Outcome, Aorta, Thoracic surgery, Blood Vessel Prosthesis Implantation adverse effects, Aortic Dissection surgery, Marfan Syndrome surgery
- Abstract
Introduction: Acute aortic dissection Stanford type A (AADA) is a surgical emergency associated with high morbidity and mortality. Although surgical management has improved, the optimal therapy is a matter of debate. Different surgical strategies have been proposed for patients under 60 years old. This paper evaluates the postoperative outcome and the need for secondary aortic operation after a limited surgical approach (proximal arch replacement) vs. extended arch repair., Methods: Between January 2000 and January 2018, 530 patients received surgical treatment for AADA at our hospital; 182 were under 60 years old and were enrolled in this study - Group A (n=68), limited arch repair (proximal arch replacement), and group B (n=114), extended arch repair (> proximal arch replacement)., Results: More pericardial tamponade (P=0.005) and preoperative mechanical resuscitation (P=0.014) were seen in Group A. More need for renal replacement therapy (P=0.047) was seen in the full arch group. Mechanical ventilation time (P=0.022) and intensive care unit stay (P<0.001) were shorter in the limited repair group. Thirty-day mortality was comparable (P=0.117). New onset of postoperative stroke was comparable (Group A four patients [5.9%] vs. Group B 15 patients [13.2%]; P=0.120). Long-term follow-up did not differ significantly for secondary aortic surgery., Conclusion: Even though young patients received only limited arch repair, the outcome was comparable. Full-arch replacement was not beneficial in the long-time follow-up. A limited approach is justified in the cohort of young AADA patients. Exemptions, like known Marfan syndrome and the presence of an intimal tear in the arch, should be considered.
- Published
- 2023
- Full Text
- View/download PDF
20. Lung transplant and severe coronary artery disease: results from a single-centre experience.
- Author
-
Franz M, Siemeni T, Aburahma K, Yablonski P, Poyanmehr R, Avsar M, Bobylev D, Sommer W, Boethig D, Greer M, Gottlieb J, Tudorache I, Hoeper MM, Warnecke G, Haverich A, Kuehn C, Ius F, and Salman J
- Subjects
- Adult, Coronary Angiography, Follow-Up Studies, Humans, Male, Retrospective Studies, Survival Rate, Treatment Outcome, Coronary Artery Disease surgery, Lung Transplantation
- Abstract
Objectives: The management of severe coronary artery disease at the time of a lung transplant remains a challenge. We analysed the short- and long-term outcomes of lung transplant recipients with severe coronary artery disease., Methods: Records of adult patients who received transplants at our institution between April 2010 and February 2021 were reviewed retrospectively. Severe coronary artery disease was defined as coronary stenosis ≥70% (main stem ≥50%) seen on the coronary angiographic scans performed before or at the time of listing. Patient characteristics, perioperative and long-term outcomes were compared between patients with and without severe coronary artery disease., Results: Among 896 patients who received lung transplants who had undergone coronary angiography before the transplant, 77 (8.5%) had severe coronary artery disease; the remaining 819 (91.5%) did not. Patients with severe coronary artery disease were older (p < 0.0001), more often male (p < 0.0001) and received transplants more often for pulmonary fibrosis (p = 0.0007). The median (interquartile range) follow-up was 46 (20-76) months. At the Cox multivariable analysis, severe coronary artery disease was not associated with death. Patients with pretransplant percutaneous transluminal coronary angioplasty and patients with coronary artery bypass graft surgery concomitant to a transplant had survival equivalent to that of patients without severe coronary artery disease (p = 0.513; p = 0.556)., Conclusions: Severe coronary artery disease was not associated with decreased survival after a lung transplant. Concomitant coronary artery bypass graft surgery and pretransplant percutaneous transluminal coronary angioplasty can be used for revascularization., (© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
21. Increased frequency of CD4 + CD25 high CD127 low T cells early after lung transplant is associated with improved graft survival - a retrospective study.
- Author
-
Ius F, Salman J, Knoefel AK, Sommer W, Nakagiri T, Verboom M, Siemeni T, Poyanmehr R, Bobylev D, Kuehn C, Avsar M, Erdfelder C, Hallensleben M, Boethig D, Hecker H, Schwerk N, Mueller C, Welte T, Falk C, Preissler G, Haverich A, Tudorache I, and Warnecke G
- Subjects
- Flow Cytometry, Humans, Interleukin-2 Receptor alpha Subunit, Retrospective Studies, T-Lymphocytes, Regulatory, Graft Survival, Lung Transplantation
- Abstract
In this retrospective study, we analyzed the presence of any association of three CD4
+ CD25high regulatory T-cell subpopulations at 3 weeks after lung transplantation with the later incidence of chronic lung allograft dysfunction and graft survival. Among lung-transplanted patients between January 2009 and April 2018, only patients with sufficient T-cell measurements at 3 weeks after transplantation were included into the study. Putative regulatory T cells were defined as CD4+ CD25high T cells, detected in peripheral blood and further analyzed for CD127low , FoxP3+ , and CD152+ using fluorescence-activated cell sorting (FACS) analysis. Associations of regulatory T cells with chronic lung allograft dysfunction (CLAD) and graft survival were evaluated using Cox analysis. During the study period, 724 (71%) patients were included into the study. Freedom from chronic lung allograft dysfunction (CLAD) and graft survival amounted to 66% and 68% at 5 years. At the multivariable analysis, increasing frequencies of CD127low were associated with better freedom from CLAD (hazard ratio for each 1% increase of %CD127low , HR = 0.989, 95% CI = 0.981-0.996, P = 0.003) and better graft survival (HR = 0.991, 95% CI = 0.984-0.999, P = 0.026). A higher frequency of CD127low regulatory T cells in peripheral blood early after lung transplantation estimated a protective effect against chronic lung allograft dysfunction, mortality, and re-transplantation., (© 2020 Steunstichting ESOT.)- Published
- 2020
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.